Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccines For Type 1 Diabetes: Prevention or Reversal?
Desai S, Buchade S, Chitlange S, Sharma H, Bhombe D, Shewale S, Pujari P. Desai S, et al. Among authors: pujari p. Curr Diabetes Rev. 2021;17(1):30-36. doi: 10.2174/1573399816666200330145501. Curr Diabetes Rev. 2021. PMID: 32223735 Review.
Th1-Th2 Seesaw: An Essential Aspect in Type 1 Diabetes.
Desai S, Bhonde R, Sharma H, Kamble P, Shimpi J, Pujari P, Parekh S, Shewale S. Desai S, et al. Among authors: pujari p. Curr Diabetes Rev. 2022;18(8):e080322201918. doi: 10.2174/1573399818666220308162514. Curr Diabetes Rev. 2022. PMID: 35260057 No abstract available.
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
Sharma H, Lalwani S, Parekh S, Pujari P, Shewale S, Palkar S, Hanumante N, Gokhale S, Ks J, Kumar R, Sharma I, Gairola S. Sharma H, et al. Among authors: pujari p. Hum Vaccin Immunother. 2022 Nov 30;18(6):2146435. doi: 10.1080/21645515.2022.2146435. Epub 2022 Nov 22. Hum Vaccin Immunother. 2022. PMID: 36412272 Free PMC article. Clinical Trial.
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
Sharma HJ, Parekh S, Pujari P, Shewale S, Desai S, Kawade A, Ravi M, Oswal J, James S, Mahantashetti N, Munshi R, Ghosh A, Rao V, Balsubramaniam S, Varughese P, Somshekhar A, Ginsburg AS, Rao H, Gautam M, Gairola S, Shaligram U. Sharma HJ, et al. Among authors: pujari p. Expert Rev Vaccines. 2023 Jan-Dec;22(1):278-287. doi: 10.1080/14760584.2023.2188942. Expert Rev Vaccines. 2023. PMID: 36883291 Free article. Clinical Trial.
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Sharma H, Anil K, Parekh S, Pujari P, Shewale S, Desai S, Madhusudhan RL, Patel J, Eswaraiah A, Rao H, Gairola S, Shaligram U. Sharma H, et al. Among authors: pujari p. Vaccine X. 2023 May 10;14:100313. doi: 10.1016/j.jvacx.2023.100313. eCollection 2023 Aug. Vaccine X. 2023. PMID: 37234594 Free PMC article.
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin.
Rathod V, Kadam L, Gautam M, Gumma PD, Marke K, Asokanathan C, Douglas-Bardsley A, Hassell L, Bhandare S, Gupta S, Parekh S, Pujari P, Rao H, Sharma H, Shaligram U, Gairola S. Rathod V, et al. Among authors: pujari p. Front Immunol. 2023 Jun 5;14:1190404. doi: 10.3389/fimmu.2023.1190404. eCollection 2023. Front Immunol. 2023. PMID: 37342321 Free PMC article.
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Aydin I, May M, Pisano F, Mpofu-Maetzig N, Grode L, Parekh S, Pujari P, Shewale S, Desai S, Sharma H, Rao H, Gautam M, Gairola S, Shaligram U. Aydin I, et al. Among authors: pujari p. Vaccine. 2023 Oct 10:S0264-410X(23)01157-X. doi: 10.1016/j.vaccine.2023.09.060. Online ahead of print. Vaccine. 2023. PMID: 37827966
73 results